InvestorsHub Logo
Followers 230
Posts 21493
Boards Moderated 2
Alias Born 08/03/2006

Re: bradfordbros post# 206918

Friday, 12/08/2017 11:28:24 AM

Friday, December 08, 2017 11:28:24 AM

Post# of 403121
B-OM data expected any day. It wasn't a very large trial since the design was just to better nail down the WHO grade.

Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Supportive Care

Official Title: Phase 2 Study to Evaluate the Efficacy & Safety of Brilacidin Oral Rinse Administered Daily for 7 Weeks in Attenuating Oral Mucositis in Patients With Head & Neck Cancer Receiving Chemoradiation

Trial link...
https://clinicaltrials.gov/ct2/show/NCT02324335?term=cellceutix&rank=3

A couple blog articles...

https://www.ipharminc.com/new-blog/2017/11/21/brilacidin-as-a-successful-example-of-de-novo-drug-design

https://www.ipharminc.com/new-blog/2017/10/17/the-market-opportunity-in-oral-mucositis

Putting the word out to more of my followers. Getting closer and closer.

Nice consolidation from the .60/.70's.

Could very well grow some nice legs!

$IPIX

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News